tiprankstipranks
NewAmsterdam Pharma Company (NAMS)
NASDAQ:NAMS
US Market
NAMS
NewAmsterdam Pharma Company
RESEARCH TOOLSreports

NewAmsterdam Pharma Company (NAMS) Balance Sheet

248 Followers

NewAmsterdam Pharma Company Balance Sheet

NewAmsterdam Pharma Company's total assets for Q4 2025 were $769.28M, a decrease of -2.18% from the previous quarter. NAMS total liabilities were $85.85M for the fiscal quarter, a 47.12% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 25Dec 24Dec 23Mar 23Dec 21
Total Assets
$ 769.28M$ 864.62M$ 347.10M$ 478.50M$ 67.99M
Total Liabilities
$ 85.85M$ 107.12M$ 58.70M$ 48.43M$ 11.36M
Total Equity Gross Minority
$ 683.43M$ 757.50M$ 288.39M$ 430.07M$ 56.63M
Other Metrics
Currency in USD

NewAmsterdam Pharma Company Debt to Assets